Oral PCSK9 Inhibitors: Can Novel Therapies Overcome Barriers to Effective LDL-Cholesterol Management?

Christie M. Ballantyne, Alberico L. Catapano, Khurram Nasir

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish (US)
Pages (from-to)2008-2010
Number of pages3
JournalJournal of the American College of Cardiology
Volume85
Issue number21
DOIs
StatePublished - Jun 3 2025

Keywords

  • adherence
  • LDL-C-lowering therapy
  • PCSK9 inhibitors
  • treatment practice

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this